Autopsy report · NCT02563522

Safety and Efficacy Study of Engensis (VM202) in the Treatment of Chronic Non-Healing Foot Ulcers

“Low enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 9 months before it started.
• Ran for about 2 years 3 months before it stopped.
• 44 participants enrolled.
• Results were posted on the registry 3 years 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Helixmith Co., Ltd.

Sponsor type

Industry

Conditions

Foot Ulcer, Diabetic

Interventions

Engensis (VM202); Placebo

Participants

44

Sites

22

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.